0001140361-15-031824.txt : 20150814
0001140361-15-031824.hdr.sgml : 20150814
20150814092946
ACCESSION NUMBER: 0001140361-15-031824
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150813
FILED AS OF DATE: 20150814
DATE AS OF CHANGE: 20150814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JOULWAN GEORGE A
CENTRAL INDEX KEY: 0001222197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 151052880
4
1
doc1.xml
FORM 4
X0306
4
2015-08-13
0
0001367644
Emergent BioSolutions Inc.
EBS
0001222197
JOULWAN GEORGE A
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2015-08-13
4
M
0
7200
17.51
A
26700
D
Common Stock
2015-08-13
4
S
0
7200
34.72
D
19500
D
Common Stock
17.51
2015-08-13
4
M
0
7200
0
D
2020-07-16
Common Stock
7200
3600
D
Consists of an option granted under the company's stock incentive plan on July 17, 2013.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.71 to $34.81, inclusive.
The option vests in three equal installments in July 2014, 2015 and 2016.
/s/ Eric Burt, attorney-in-fact
2015-08-14